Live feed08:05:00·24dPRReleaseGuardant Health's InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in JapanGH· Guardant Health Inc.Health CareOriginal source
